First Time Loading...
O

Ortivus AB
STO:ORTI B

Watchlist Manager
Ortivus AB
STO:ORTI B
Watchlist
Price: 2.53 SEK
Updated: May 23, 2024

Intrinsic Value

Ortivus AB engages in the development and sale of clinical devices and systems. [ Read More ]

The intrinsic value of one ORTI B stock under the Base Case scenario is 2.49 SEK. Compared to the current market price of 2.53 SEK, Ortivus AB is Overvalued by 2%.

Key Points:
ORTI B Intrinsic Value
Base Case
2.49 SEK
Overvaluation 2%
Intrinsic Value
Price
O
Worst Case
Base Case
Best Case

Valuation Backtest
Ortivus AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ORTI B stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Ortivus AB

Provide an overview of the primary business activities
of Ortivus AB.

What unique competitive advantages
does Ortivus AB hold over its rivals?

What risks and challenges
does Ortivus AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ortivus AB.

Provide P/S
for Ortivus AB.

Provide P/E
for Ortivus AB.

Provide P/OCF
for Ortivus AB.

Provide P/FCFE
for Ortivus AB.

Provide P/B
for Ortivus AB.

Provide EV/S
for Ortivus AB.

Provide EV/GP
for Ortivus AB.

Provide EV/EBITDA
for Ortivus AB.

Provide EV/EBIT
for Ortivus AB.

Provide EV/OCF
for Ortivus AB.

Provide EV/FCFF
for Ortivus AB.

Provide EV/IC
for Ortivus AB.

What are the Revenue projections
for Ortivus AB?

How accurate were the past Revenue estimates
for Ortivus AB?

What are the Net Income projections
for Ortivus AB?

How accurate were the past Net Income estimates
for Ortivus AB?

What are the EPS projections
for Ortivus AB?

How accurate were the past EPS estimates
for Ortivus AB?

What are the EBIT projections
for Ortivus AB?

How accurate were the past EBIT estimates
for Ortivus AB?

Compare the revenue forecasts
for Ortivus AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ortivus AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ortivus AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ortivus AB compared to its peers.

Compare the P/E ratios
of Ortivus AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Ortivus AB with its peers.

Analyze the financial leverage
of Ortivus AB compared to its main competitors.

Show all profitability ratios
for Ortivus AB.

Provide ROE
for Ortivus AB.

Provide ROA
for Ortivus AB.

Provide ROIC
for Ortivus AB.

Provide ROCE
for Ortivus AB.

Provide Gross Margin
for Ortivus AB.

Provide Operating Margin
for Ortivus AB.

Provide Net Margin
for Ortivus AB.

Provide FCF Margin
for Ortivus AB.

Show all solvency ratios
for Ortivus AB.

Provide D/E Ratio
for Ortivus AB.

Provide D/A Ratio
for Ortivus AB.

Provide Interest Coverage Ratio
for Ortivus AB.

Provide Altman Z-Score Ratio
for Ortivus AB.

Provide Quick Ratio
for Ortivus AB.

Provide Current Ratio
for Ortivus AB.

Provide Cash Ratio
for Ortivus AB.

What is the historical Revenue growth
over the last 5 years for Ortivus AB?

What is the historical Net Income growth
over the last 5 years for Ortivus AB?

What is the current Free Cash Flow
of Ortivus AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ortivus AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ortivus AB

Current Assets 33.9m
Cash & Short-Term Investments 1.3m
Receivables 11.2m
Other Current Assets 21.4m
Non-Current Assets 33m
Long-Term Investments 4m
PP&E 5.2m
Intangibles 23.8m
Current Liabilities 38.5m
Accounts Payable 9.3m
Accrued Liabilities 13.8m
Short-Term Debt 8m
Other Current Liabilities 7.4m
Non-Current Liabilities 12.8m
Long-Term Debt 3.2m
Other Non-Current Liabilities 9.6m
Efficiency

Earnings Waterfall
Ortivus AB

Revenue
78.1m SEK
Cost of Revenue
-51.7m SEK
Gross Profit
26.5m SEK
Operating Expenses
-46.6m SEK
Operating Income
-20.1m SEK
Other Expenses
-477k SEK
Net Income
-20.6m SEK

Free Cash Flow Analysis
Ortivus AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ORTI B Profitability Score
Profitability Due Diligence

Ortivus AB's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Negative Operating Income
35/100
Profitability
Score

Ortivus AB's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ORTI B Solvency Score
Solvency Due Diligence

Ortivus AB's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
44/100
Solvency
Score

Ortivus AB's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ORTI B Price Targets Summary
Ortivus AB

There are no price targets for ORTI B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Ortivus AB

Shareholder Return

ORTI B Price
Ortivus AB

1M 1M
-4%
6M 6M
-18%
1Y 1Y
-41%
3Y 3Y
-50%
5Y 5Y
+33%
10Y 10Y
-54%
Annual Price Range
2.53
52w Low
2.19
52w High
4.99
Price Metrics
Average Annual Return 39.14%
Standard Deviation of Annual Returns 51.18%
Max Drawdown -71%
Shares Statistics
Market Capitalization 112.1m SEK
Shares Outstanding 44 310 000
Percentage of Shares Shorted
N/A

ORTI B Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Ortivus AB

Country

Sweden

Industry

Health Care

Market Cap

112.1m SEK

Dividend Yield

0%

Description

Ortivus AB engages in the development and sale of clinical devices and systems. The company is headquartered in Danderyd, Stockholm. The firm is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.

Contact

STOCKHOLM
Danderyd
Svardvagen 19
+4684464500
https://www.ortivus.com/

IPO

1997-01-02

Employees

-

Officers

Chief Executive Officer
Mr. Gustaf Nordenhok
Chief Financial Officer
Viveka Hiort af Ornas
Marketing & Communications Manager
Ms. Joanna Daffy Tiitus
Customer & Sales Manager
Mr. Elias Obaid

See Also

Discover More
What is the Intrinsic Value of one ORTI B stock?

The intrinsic value of one ORTI B stock under the Base Case scenario is 2.49 SEK.

Is ORTI B stock undervalued or overvalued?

Compared to the current market price of 2.53 SEK, Ortivus AB is Overvalued by 2%.